Form 4: Century Therapeutics CEO Sells Shares for Tax Obligations
Insider Transaction Report
Century Therapeutics' President and CEO, Brent Pfeiffenberger, sold 32,456 shares of common stock to cover tax withholding obligations related to RSU vesting.
Summary
- Brent Pfeiffenberger, President and CEO, and a Director of Century Therapeutics, Inc. (IPSC), reported a transaction involving the company's common stock.
- On November 17, 2025, Pfeiffenberger sold 32,456 shares of Century Therapeutics common stock.
- The shares were sold at a price of $0.454 per share.
- Following this transaction, Pfeiffenberger beneficially owns 3,236,453 shares of common stock.
- The sale was non-discretionary and executed solely to cover tax withholding obligations associated with the vesting of restricted stock units.
Sentiment
Score: 5
Explanation: A neutral event. The sale was non-discretionary and for tax purposes, which is a common occurrence for executives receiving equity compensation. It does not indicate a change in management's outlook on the company.
Future Outlook
The filing does not contain any forward-looking statements or guidance.
Management Comments
- The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units.
- Such sales were automatic and not at the discretion of the Reporting Person.
Industry Context
This is a routine insider transaction for tax purposes and does not reflect broader industry trends or competitive positioning. It is a standard event for executives receiving equity compensation.
Stakeholder Impact
- Shareholders: The sale is a routine, non-discretionary event for tax purposes and is unlikely to signal a change in management confidence or company fundamentals. The number of shares sold represents a small fraction of the CEO's total beneficial ownership.
- Employees: No direct impact on employees is indicated.
Key Dates
| Date | Description |
|---|---|
| 11/17/2025 | Date of earliest transaction (sale of common stock) |
| 11/19/2025 | Date Form 4 was signed and filed |
Keywords
Century Therapeutics, IPSC, Brent Pfeiffenberger, Insider Sale, Form 4, Restricted Stock Units, Tax Withholding, CEO, Director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.